ID: ALA3321917

Max Phase: Preclinical

Molecular Formula: C18H19ClN4O5

Molecular Weight: 406.83

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(CC(=O)NC(=N)NCc2ccccc2Cl)c([N+](=O)[O-])cc1OC

Standard InChI:  InChI=1S/C18H19ClN4O5/c1-27-15-7-12(14(23(25)26)9-16(15)28-2)8-17(24)22-18(20)21-10-11-5-3-4-6-13(11)19/h3-7,9H,8,10H2,1-2H3,(H3,20,21,22,24)

Standard InChI Key:  IAFNAOLFUJQPAB-UHFFFAOYSA-N

Associated Targets(Human)

Renin 5251 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cathepsin D 3201 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cathepsin D 510 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 406.83Molecular Weight (Monoisotopic): 406.1044AlogP: 2.65#Rotatable Bonds: 7
Polar Surface Area: 126.58Molecular Species: BASEHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.53CX Basic pKa: 8.54CX LogP: 2.76CX LogD: 1.62
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.28Np Likeness Score: -1.08

References

1. Grädler U, Czodrowski P, Tsaklakidis C, Klein M, Werkmann D, Lindemann S, Maskos K, Leuthner B..  (2014)  Structure-based optimization of non-peptidic Cathepsin D inhibitors.,  24  (17): [PMID:25086681] [10.1016/j.bmcl.2014.07.054]

Source